Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers [NA]
This clinical trial update covers the LEAD IT! app, which aims to help people with early-stage dementia lead activities for their peers. The…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG [Phase 2]
The Phase 2 pilot study of CT1812 in mild-to-moderate Alzheimer disease using EEG has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease [NA]
A program to reduce inappropriate medications among older adults with Alzheimer's disease completed. Results from the trial have been posted…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease [NA]
This clinical trial update describes exploring lymphaticovenous anastomosis as a potential treatment for Alzheimer's disease and its possibl…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid [Phase 2, Phase 3]
Phase 2/Phase 3 trial assessing brain amyloid and vascular effects of eicosapentaenoic acid in Alzheimer's disease completed with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: An Objective Assessment Tool for Evaluating Functioning in Older Adults
Ongoing Stanford clinical trial evaluating an objective assessment tool for functioning in older adults with Alzheimer disease. The study st…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study of Seltorexant in Participants With Probable Alzheimer's Disease [Phase 2]
Phase 2 study evaluating Seltorexant in participants with probable Alzheimer's disease has completed and posted results.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)" [NA]
Ongoing clinical trial recruitment for a study investigating whether exercise can reduce Alzheimer's disease risk among African Americans.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Ruijin Neurobank of Alzheimer's Disease and Dementia
A ClinicalTrials.gov entry for the Ruijin Neurobank of Alzheimer's Disease and Dementia. The sponsor is Ruijin Hospital, and the study is cu…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Promoting Independence With Compensatory Cognitive Rehabilitation [NA]
University of Delaware is sponsoring a clinical trial that recruits participants to test compensatory cognitive rehabilitation aimed at prom…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease [NA]
Clinical trial update for a Shanghai-based non-pharmacological intervention targeting mild cognitive impairment and early-stage Alzheimer's …
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study
This clinical trial update describes the validation of blood biomarkers as a screening tool for Alzheimer's disease, focusing on their clini…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
Clinical trial ECOCAPTURE is assessing apathy in real-world settings for patients with frontottemporal dementia with behavioral variant and …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Alzheimer's Disease Neuroimaging Initiative 2
This ClinicalTrials.gov entry provides a completed update for the Alzheimer's Disease Neuroimaging Initiative 2 study, covering conditions i…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial update evaluating AVP-786 for agitation in Alzheimer's disease has completed, assessing efficacy, safety, and tolerability.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: An Observational Study of Patients Living With Chronic Neurological Diseases
An observational study update on patients living with chronic neurological diseases, including Alzheimer disease, mild cognitive impairment,…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease [Phase 2]
Phase 2 open-label proof-of-concept study in early Alzheimer's disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease [Phase 2]
A phase 2 clinical trial evaluating the efficacy and safety of Astragalus membranaceus in mild-to-moderate Alzheimer's disease has completed…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Community-based Brain Health Program to Address Dementia Risk [NA]
Clinical trial update reports that a community-based brain health program designed to address dementia risk has completed the study. The pro…
-
EMA approval · 2024-11-15Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2024
The CHMP recommended Leqembi (lecanemab) for the treatment of early Alzheimer's disease, indicating EMA support ahead of final authorization…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Long-term Efficacy and Safety Study of GV-971 [Phase 4]
This document reports a Phase 4 long-term efficacy and safety study of GV-971 for Alzheimer's disease, with the trial currently active but n…
-
EMA approval · 2024-11-14Leqembi recommended for treatment of early Alzheimer’s disease
The EMA CHMP recommended Leqembi (lecanemab) for treatment of early Alzheimer's disease in a restricted patient population after a re-examin…
-
FDA approval · 2024-11-14FDA Approved: LEQEMBI — Supplemental Application (Eisai Inc.)
The FDA approved a supplemental application for LEQEMBI (lecanemab) submitted by Eisai Inc.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type [Phase 2, Phase 3]
This document reports the completion and results posting of a Phase 2/3 clinical trial evaluating brexpiprazole for agitation in Alzheimer's…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
FLOWER is a longitudinal epidemiology study by xCures to follow outcomes across multiple rare diseases, and the study is currently recruitin…